Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Development and Characterisation of a Rat Model of Parkinson's Disease

Negrini, Matilde LU (2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
Abstract
Preclinical rodent models of Parkinson’s Disease (PD) based on alpha-synuclein (αSyn) present some of the pathological hallmarks of the human condition, such as the progressive loss of dopaminergic neurons in the substantia nigra (SN) and the development of behavioural deficits. However, numerous reports on these models highlighted the variable outcomes that might originate from them if not validated properly. This thesis seeks to develop and characterise a rat model of PD, which present stable and relevant pathology and to be utilised for the investigation of disease progression and the assessment of therapeutic interventions. At first, we compared different αSyn models based on the injection of an adeno-associated virus (AAV)... (More)
Preclinical rodent models of Parkinson’s Disease (PD) based on alpha-synuclein (αSyn) present some of the pathological hallmarks of the human condition, such as the progressive loss of dopaminergic neurons in the substantia nigra (SN) and the development of behavioural deficits. However, numerous reports on these models highlighted the variable outcomes that might originate from them if not validated properly. This thesis seeks to develop and characterise a rat model of PD, which present stable and relevant pathology and to be utilised for the investigation of disease progression and the assessment of therapeutic interventions. At first, we compared different αSyn models based on the injection of an adeno-associated virus (AAV) overexpressing human αSyn and/or the inoculation of preformed fibrils (PFFs). Although some additional pathology (i.e. increased protein aggregation and inflammation) could be obtained by combining AAV-αSyn and PFFs, AAV-αSyn alone was sufficient to generate a model that would present neuronal loss, Lewy-like pathology, and behavioural impairments. We, therefore, further investigated the ability of AAV-αSyn to model early stages of PD. We could detect a progressive development of motor and cognitive symptoms by using simple drug-free behavioural tests and concomitant neuronal loss in the SN. Subsequently, we demonstrated, for the first time in an AAV-αSyn model, attentional neglect, as well as deficits in movement initiation and movement completion using a lateralised choice reaction time task. Eventually, we tested whether our newly characterised model could be useful in the assessment of disease-modifying therapies, such as the injection of neurotrophic factors. We, therefore, tested the potential beneficial effects of a new candidate among them, the growth differentiation factor 5 (GDF5). Unfortunately, the injection of AAV-GDF5 did not exert any neuroprotective effect in our model. Taken together, these results show that it was possible to replicate our AAV- αSyn rat model between studies, and it presents stable neurodegeneration, synucleinopathy, as well as motor and cognitive deficits which can be assessed by a wide battery of simple and complex behavioural tests. (Less)
Please use this url to cite or link to this publication:
author
supervisor
opponent
  • professor Airavaara, Mikko, University of Helsinki, Finland
organization
publishing date
type
Thesis
publication status
published
subject
keywords
Parkinson's disease (PD), behavior, gene therapy, rat model, dopamine, alpha-synuclein, AAV (Adeno-Associated virus), PFFs
in
Lund University, Faculty of Medicine Doctoral Dissertation Series
issue
2022:143
pages
87 pages
publisher
Lund University, Faculty of Medicine
defense location
Segerfalksalen, BMC A10, Sölvegatan 17 i Lund
defense date
2022-11-04 13:00:00
ISSN
1652-8220
ISBN
978-91-8021-305-9
language
English
LU publication?
yes
id
9feb8a94-bf61-4082-a939-78047101a223
date added to LUP
2022-10-10 10:36:36
date last changed
2023-05-17 09:09:16
@phdthesis{9feb8a94-bf61-4082-a939-78047101a223,
  abstract     = {{Preclinical rodent models of Parkinson’s Disease (PD) based on alpha-synuclein (αSyn) present some of the pathological hallmarks of the human condition, such as the progressive loss of dopaminergic neurons in the substantia nigra (SN) and the development of behavioural deficits. However, numerous reports on these models highlighted the variable outcomes that might originate from them if not validated properly. This thesis seeks to develop and characterise a rat model of PD, which present stable and relevant pathology and to be utilised for the investigation of disease progression and the assessment of therapeutic interventions. At first, we compared different αSyn models based on the injection of an adeno-associated virus (AAV) overexpressing human αSyn and/or the inoculation of preformed fibrils (PFFs). Although some additional pathology (i.e. increased protein aggregation and inflammation) could be obtained by combining AAV-αSyn and PFFs, AAV-αSyn alone was sufficient to generate a model that would present neuronal loss, Lewy-like pathology, and behavioural impairments. We, therefore, further investigated the ability of AAV-αSyn to model early stages of PD. We could detect a progressive development of motor and cognitive symptoms by using simple drug-free behavioural tests and concomitant neuronal loss in the SN. Subsequently, we demonstrated, for the first time in an AAV-αSyn model, attentional neglect, as well as deficits in movement initiation and movement completion using a lateralised choice reaction time task. Eventually, we tested whether our newly characterised model could be useful in the assessment of disease-modifying therapies, such as the injection of neurotrophic factors. We, therefore, tested the potential beneficial effects of a new candidate among them, the growth differentiation factor 5 (GDF5). Unfortunately, the injection of AAV-GDF5 did not exert any neuroprotective effect in our model. Taken together, these results show that it was possible to replicate our AAV- αSyn rat model between studies, and it presents stable neurodegeneration, synucleinopathy, as well as motor and cognitive deficits which can be assessed by a wide battery of simple and complex behavioural tests.}},
  author       = {{Negrini, Matilde}},
  isbn         = {{978-91-8021-305-9}},
  issn         = {{1652-8220}},
  keywords     = {{Parkinson's disease (PD); behavior; gene therapy; rat model; dopamine; alpha-synuclein; AAV (Adeno-Associated virus); PFFs}},
  language     = {{eng}},
  number       = {{2022:143}},
  publisher    = {{Lund University, Faculty of Medicine}},
  school       = {{Lund University}},
  series       = {{Lund University, Faculty of Medicine Doctoral Dissertation Series}},
  title        = {{Development and Characterisation of a Rat Model of Parkinson's Disease}},
  url          = {{https://lup.lub.lu.se/search/files/125991793/Development_and_Characterisation_of_a_Rat_Model_of_Parkinson_s_Disease.pdf}},
  year         = {{2022}},
}